This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...

Some 39,000 years ago, a woolly mammoth died in present-day Siberia, destined to be blanketed by ice and permafrost that would end up preserving its body — even down to the hair and muscle. Now, that ...

RNA sequencing (RNA-Seq) is a high-throughput sequencing approach that enables comprehensive quantification of transcriptomes at a genome-wide scale. As a result, RNA-Seq has become a routine ...

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive pulmonary disorder marked by the gradual substitution of lung tissue with fibrotic tissue, resulting in respiratory failure. While the ...

CD Genomics, a globally distinguished pioneer in genomic technologies, declared today the induction of their innovative LncRNA Microarray Service, affording scientists an avant-garde solution for ...

Abstract: The last few years have witnessed exponential rise in breast cancer disease. The increasing mortality rate due to the lack of earlier diagnosis has alarmed healthcare industry to develop ...

The differentially expressed genes were categorized according to known molecular functions. A proportion was associated with transcriptional control or had unknown functions: 49.0% (246/502) in DSCL ...

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.

- The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...